Besides an ALPS phenotype, patients with TET2 loss-of-function fulfilled several laboratory criteria of ALPS, including increased proportion of double-negative T cells (three out of five reported patients) and impaired Fas-dependent apoptosis (two out of four tested patients). Here, TET2 is linked to autoimmune lymphoproliferative syndrome.